Human Growth Hormone
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
1 Follicle Stimulating Hormone Market Overview 1.1 Product Overview and Scope of Follicle Stimulating Hormone 1.2 Follicle Stimulating Hormone Segment by Type 1.2.1 Global Follicle Stimulating Hormone Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Recombinant FSH 1.2.3 Urinary FSH 1.3 Follicle Stimulating Hormone Segment by Application 1.3.1 Global Follicle Stimulating Hormone Sales Comparison by Application: (2021-2027) 1.3.2 Infertility Treatment 1.3.3 Assisted Reproductive Technology 1.4 Global Follicle Stimulating Hormone Market Size Estimates and Forecasts 1.4.1 Global Follicle Stimulating Hormone Revenue 2016-2027 1.4.2 Global Follicle Stimulating Hormone Sales 2016-2027 1.4.3 Follicle Stimulating Hormone Market Size by Region: 2016 Versus 2021 Versus 2027 2 Follicle Stimulating Hormone Market Competition by Manufacturers 2.1 Global Follicle Stimulating Hormone Sales Market Share by Manufacturers (2016-2021) 2.2 Global Follicle Stimulating Hormone Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Follicle Stimulating Hormone Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Follicle Stimulating Hormone Manufacturing Sites, Area Served, Product Type 2.5 Follicle Stimulating Hormone Market Competitive Situation and Trends 2.5.1 Follicle Stimulating Hormone Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Follicle Stimulating Hormone Players Market Share by Revenue 2.5.3 Global Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Follicle Stimulating Hormone Retrospective Market Scenario by Region 3.1 Global Follicle Stimulating Hormone Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Follicle Stimulating Hormone Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Follicle Stimulating Hormone Market Facts & Figures by Country 3.3.1 North America Follicle Stimulating Hormone Sales by Country 3.3.2 North America Follicle Stimulating Hormone Revenue by Country 3.4 Europe Follicle Stimulating Hormone Market Facts & Figures by Country 3.4.1 Europe Follicle Stimulating Hormone Sales by Country 3.4.2 Europe Follicle Stimulating Hormone Revenue by Country 3.4.3 Poland 3.5 Asia Pacific Follicle Stimulating Hormone Market Facts & Figures by Region 3.5.1 Asia Pacific Follicle Stimulating Hormone Sales by Region 3.5.2 Asia Pacific Follicle Stimulating Hormone Revenue by Region 3.6 Latin America Follicle Stimulating Hormone Market Facts & Figures by Country 3.6.1 Latin America Follicle Stimulating Hormone Sales by Country 3.6.2 Latin America Follicle Stimulating Hormone Revenue by Country 3.7 Middle East and Africa Follicle Stimulating Hormone Market Facts & Figures by Country 3.7.1 Middle East and Africa Follicle Stimulating Hormone Sales by Country 3.7.2 Middle East and Africa Follicle Stimulating Hormone Revenue by Country 4 Global Follicle Stimulating Hormone Historic Market Analysis by Type 4.1 Global Follicle Stimulating Hormone Sales Market Share by Type (2016-2021) 4.2 Global Follicle Stimulating Hormone Revenue Market Share by Type (2016-2021) 4.3 Global Follicle Stimulating Hormone Price by Type (2016-2021) 5 Global Follicle Stimulating Hormone Historic Market Analysis by Application 5.1 Global Follicle Stimulating Hormone Sales Market Share by Application (2016-2021) 5.2 Global Follicle Stimulating Hormone Revenue Market Share by Application (2016-2021) 5.3 Global Follicle Stimulating Hormone Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Merck Serono 6.1.1 Merck Serono Corporation Information 6.1.2 Merck Serono Description and Business Overview 6.1.3 Merck Serono Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Merck Serono Follicle Stimulating Hormone Product Portfolio 6.1.5 Merck Serono Recent Developments/Updates 6.2 MSD 6.2.1 MSD Corporation Information 6.2.2 MSD Description and Business Overview 6.2.3 MSD Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021) 6.2.4 MSD Follicle Stimulating Hormone Product Portfolio 6.2.5 MSD Recent Developments/Updates 6.3 IBSA 6.3.1 IBSA Corporation Information 6.3.2 IBSA Description and Business Overview 6.3.3 IBSA Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021) 6.3.4 IBSA Follicle Stimulating Hormone Product Portfolio 6.3.5 IBSA Recent Developments/Updates 6.4 Ferring 6.4.1 Ferring Corporation Information 6.4.2 Ferring Description and Business Overview 6.4.3 Ferring Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Ferring Follicle Stimulating Hormone Product Portfolio 6.4.5 Ferring Recent Developments/Updates 6.5 Livzon 6.5.1 Livzon Corporation Information 6.5.2 Livzon Description and Business Overview 6.5.3 Livzon Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Livzon Follicle Stimulating Hormone Product Portfolio 6.5.5 Livzon Recent Developments/Updates 6.6 Techwell 6.6.1 Techwell Corporation Information 6.6.2 Techwell Description and Business Overview 6.6.3 Techwell Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Techwell Follicle Stimulating Hormone Product Portfolio 6.6.5 Techwell Recent Developments/Updates 6.7 GenSci 6.6.1 GenSci Corporation Information 6.6.2 GenSci Description and Business Overview 6.6.3 GenSci Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021) 6.4.4 GenSci Follicle Stimulating Hormone Product Portfolio 6.7.5 GenSci Recent Developments/Updates 6.8 Gedeon Richter 6.8.1 Gedeon Richter Corporation Information 6.8.2 Gedeon Richter Description and Business Overview 6.8.3 Gedeon Richter Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Gedeon Richter Follicle Stimulating Hormone Product Portfolio 6.8.5 Gedeon Richter Recent Developments/Updates 6.9 Teva 6.9.1 Teva Corporation Information 6.9.2 Teva Description and Business Overview 6.9.3 Teva Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Teva Follicle Stimulating Hormone Product Portfolio 6.9.5 Teva Recent Developments/Updates 7 Follicle Stimulating Hormone Manufacturing Cost Analysis 7.1 Follicle Stimulating Hormone Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Follicle Stimulating Hormone 7.4 Follicle Stimulating Hormone Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Follicle Stimulating Hormone Distributors List 8.3 Follicle Stimulating Hormone Customers 9 Follicle Stimulating Hormone Market Dynamics 9.1 Follicle Stimulating Hormone Industry Trends 9.2 Follicle Stimulating Hormone Growth Drivers 9.3 Follicle Stimulating Hormone Market Challenges 9.4 Follicle Stimulating Hormone Market Restraints 10 Global Market Forecast 10.1 Follicle Stimulating Hormone Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Follicle Stimulating Hormone by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Follicle Stimulating Hormone by Type (2022-2027) 10.2 Follicle Stimulating Hormone Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Follicle Stimulating Hormone by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Follicle Stimulating Hormone by Application (2022-2027) 10.3 Follicle Stimulating Hormone Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Follicle Stimulating Hormone by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Follicle Stimulating Hormone by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer
List of Tables Table 1. Global Follicle Stimulating Hormone Sales (K Doses) Growth Rate Comparison by Type (2021-2027) Table 2. Global Follicle Stimulating Hormone Sales (K Doses) Comparison by Application (2021-2027) Table 3. Global Follicle Stimulating Hormone Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Follicle Stimulating Hormone Covered in This Study Table 5. Global Follicle Stimulating Hormone Sales (K Doses) of Key Manufacturers (2016-2021) Table 6. Global Follicle Stimulating Hormone Sales Market Share by Manufacturers (2016-2021) Table 7. Global Follicle Stimulating Hormone Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Follicle Stimulating Hormone Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Follicle Stimulating Hormone Average Price (USD/Dose) of Key Manufacturers (2016-2021) Table 10. Manufacturers Follicle Stimulating Hormone Manufacturing Sites and Area Served Table 11. Manufacturers Follicle Stimulating Hormone Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Follicle Stimulating Hormone by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Follicle Stimulating Hormone as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Follicle Stimulating Hormone Sales by Region (2016-2021) & (K Doses) Table 16. Global Follicle Stimulating Hormone Sales Market Share by Region (2016-2021) Table 17. Global Follicle Stimulating Hormone Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Follicle Stimulating Hormone Sales by Country (2016-2021) & (K Doses) Table 19. North America Follicle Stimulating Hormone Sales Market Share by Country (2016-2021) Table 20. North America Follicle Stimulating Hormone Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Follicle Stimulating Hormone Revenue Market Share by Country (2016-2021) Table 22. Europe Follicle Stimulating Hormone Sales by Country (2016-2021) & (K Doses) Table 23. Europe Follicle Stimulating Hormone Sales Market Share by Country (2016-2021) Table 24. Europe Follicle Stimulating Hormone Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Follicle Stimulating Hormone Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Follicle Stimulating Hormone Sales by Region (2016-2021) & (K Doses) Table 27. Asia Pacific Follicle Stimulating Hormone Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Follicle Stimulating Hormone Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Follicle Stimulating Hormone Revenue Market Share by Region (2016-2021) Table 30. Latin America Follicle Stimulating Hormone Sales by Country (2016-2021) & (K Doses) Table 31. Latin America Follicle Stimulating Hormone Sales Market Share by Country (2016-2021) Table 32. Latin America Follicle Stimulating Hormone Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Follicle Stimulating Hormone Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Follicle Stimulating Hormone Sales by Country (2016-2021) & (K Doses) Table 35. Middle East and Africa Follicle Stimulating Hormone Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Follicle Stimulating Hormone Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Follicle Stimulating Hormone Revenue Market Share by Country (2016-2021) Table 38. Global Follicle Stimulating Hormone Sales (K Doses) by Type (2016-2021) Table 39. Global Follicle Stimulating Hormone Sales Market Share by Type (2016-2021) Table 40. Global Follicle Stimulating Hormone Revenue (Million US$) by Type (2016-2021) Table 41. Global Follicle Stimulating Hormone Revenue Share by Type (2016-2021) Table 42. Global Follicle Stimulating Hormone Price (USD/Dose) by Type (2016-2021) Table 43. Global Follicle Stimulating Hormone Sales (K Doses) by Application (2016-2021) Table 44. Global Follicle Stimulating Hormone Sales Market Share by Application (2016-2021) Table 45. Global Follicle Stimulating Hormone Revenue (Million US$) by Application (2016-2021) Table 46. Global Follicle Stimulating Hormone Revenue Share by Application (2016-2021) Table 47. Global Follicle Stimulating Hormone Price (USD/Dose) by Application (2016-2021) Table 48. Merck Serono Corporation Information Table 49. Merck Serono Description and Business Overview Table 50. Merck Serono Follicle Stimulating Hormone Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021) Table 51. Merck Serono Follicle Stimulating Hormone Product Table 52. Merck Serono Recent Developments/Updates Table 53. MSD Corporation Information Table 54. MSD Description and Business Overview Table 55. MSD Follicle Stimulating Hormone Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021) Table 56. MSD Follicle Stimulating Hormone Product Table 57. MSD Recent Developments/Updates Table 58. IBSA Corporation Information Table 59. IBSA Description and Business Overview Table 60. IBSA Follicle Stimulating Hormone Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021) Table 61. IBSA Follicle Stimulating Hormone Product Table 62. IBSA Recent Developments/Updates Table 63. Ferring Corporation Information Table 64. Ferring Description and Business Overview Table 65. Ferring Follicle Stimulating Hormone Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021) Table 66. Ferring Follicle Stimulating Hormone Product Table 67. Ferring Recent Developments/Updates Table 68. Livzon Corporation Information Table 69. Livzon Description and Business Overview Table 70. Livzon Follicle Stimulating Hormone Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021) Table 71. Livzon Follicle Stimulating Hormone Product Table 72. Livzon Recent Developments/Updates Table 73. Techwell Corporation Information Table 74. Techwell Description and Business Overview Table 75. Techwell Follicle Stimulating Hormone Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021) Table 76. Techwell Follicle Stimulating Hormone Product Table 77. Techwell Recent Developments/Updates Table 78. GenSci Corporation Information Table 79. GenSci Description and Business Overview Table 80. GenSci Follicle Stimulating Hormone Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021) Table 81. GenSci Follicle Stimulating Hormone Product Table 82. GenSci Recent Developments/Updates Table 83. Gedeon Richter Corporation Information Table 84. Gedeon Richter Description and Business Overview Table 85. Gedeon Richter Follicle Stimulating Hormone Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021) Table 86. Gedeon Richter Follicle Stimulating Hormone Product Table 87. Gedeon Richter Recent Developments/Updates Table 88. Teva Corporation Information Table 89. Teva Description and Business Overview Table 90. Teva Follicle Stimulating Hormone Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021) Table 91. Teva Follicle Stimulating Hormone Product Table 92. Teva Recent Developments/Updates Table 93. Production Base and Market Concentration Rate of Raw Material Table 94. Key Suppliers of Raw Materials Table 95. Follicle Stimulating Hormone Distributors List Table 96. Follicle Stimulating Hormone Customers List Table 97. Follicle Stimulating Hormone Market Trends Table 98. Follicle Stimulating Hormone Growth Drivers Table 99. Follicle Stimulating Hormone Market Challenges Table 100. Follicle Stimulating Hormone Market Restraints Table 101. Global Follicle Stimulating Hormone Sales Forecast by Type (2022-2027) & (K Doses) Table 102. Global Follicle Stimulating Hormone Sales Market Share Forecast by Type (2022-2027) Table 103. Global Follicle Stimulating Hormone Revenue Forecast by Type (2022-2027) & (US$ Million) Table 104. Global Follicle Stimulating Hormone Revenue Market Share Forecast by Type (2022-2027) Table 105. Global Follicle Stimulating Hormone Sales Forecast by Application (2022-2027) & (K Doses) Table 106. Global Follicle Stimulating Hormone Sales Market Share Forecast by Application (2022-2027) Table 107. Global Follicle Stimulating Hormone Revenue Forecast by Application (2022-2027) & (US$ Million) Table 108. Global Follicle Stimulating Hormone Revenue Market Share Forecast by Application (2022-2027) Table 109. Global Follicle Stimulating Hormone Sales Forecast by Region (2022-2027) & (K Doses) Table 110. Global Follicle Stimulating Hormone Sales Market Share Forecast by Region (2022-2027) Table 111. Global Follicle Stimulating Hormone Revenue Forecast by Region (2022-2027) & (US$ Million) Table 112. Global Follicle Stimulating Hormone Revenue Market Share Forecast by Region (2022-2027) Table 113. Research Programs/Design for This Report Table 114. Key Data Information from Secondary Sources Table 115. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Follicle Stimulating Hormone Figure 2. Global Follicle Stimulating Hormone Market Share by Type in 2020 & 2027 Figure 3. Recombinant FSH Product Picture Figure 4. Urinary FSH Product Picture Figure 5. Global Follicle Stimulating Hormone Market Share by Application in 2020 & 2027 Figure 6. Infertility Treatment Figure 7. Assisted Reproductive Technology Figure 8. Global Follicle Stimulating Hormone Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 9. Global Follicle Stimulating Hormone Market Size 2016-2027 (US$ Million) Figure 10. Global Follicle Stimulating Hormone Sales 2016-2027 (K Doses) Figure 11. Global Follicle Stimulating Hormone Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 12. Follicle Stimulating Hormone Sales Share by Manufacturers in 2020 Figure 13. Global Follicle Stimulating Hormone Revenue Share by Manufacturers in 2020 Figure 14. The Global 5 and 10 Largest Follicle Stimulating Hormone Players: Market Share by Revenue in 2020 Figure 15. Follicle Stimulating Hormone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 16. Global Follicle Stimulating Hormone Sales Market Share by Region (2016-2021) Figure 17. Global Follicle Stimulating Hormone Sales Market Share by Region in 2020 Figure 18. Global Follicle Stimulating Hormone Revenue Market Share by Region (2016-2021) Figure 19. Global Follicle Stimulating Hormone Revenue Market Share by Region in 2020 Figure 20. Poland Follicle Stimulating Hormone Revenue Growth Rate (2016-2021) (US$ Million) Figure 21. Sales Market Share of Follicle Stimulating Hormone by Type (2016-2021) Figure 22. Sales Market Share of Follicle Stimulating Hormone by Application (2016-2021) Figure 23. Sales Market Share of Follicle Stimulating Hormone by Application in 2020 Figure 24. Revenue Share of Follicle Stimulating Hormone by Application (2016-2021) Figure 25. Revenue Share of Follicle Stimulating Hormone by Application in 2020 Figure 26. Manufacturing Cost Structure of Follicle Stimulating Hormone Figure 27. Manufacturing Process Analysis of Follicle Stimulating Hormone Figure 28. Follicle Stimulating Hormone Industrial Chain Analysis Figure 29. Channels of Distribution Figure 30. Distributors Profiles Figure 31. Bottom-up and Top-down Approaches for This Report Figure 32. Data Triangulation Figure 33. Key Executives Interviewed
Merck Serono MSD IBSA Ferring Livzon Techwell GenSci Gedeon Richter Teva
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More